These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 932428)

  • 1. Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo.
    Small M; Trainin N
    J Immunol; 1976 Jul; 117(1):292-7. PubMed ID: 932428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing reactivities of subpopulations of T lymphocytes toward syngeneic tumor cells: separation of early thymocytes.
    Small M
    J Immunol; 1978 Sep; 121(3):1167-72. PubMed ID: 308521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.
    Small M; Trainin N
    Int J Cancer; 1975 Jun; 15(6):962-72. PubMed ID: 1150350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of immature cells from the thymus during solid tumor growth: identification by assay of TdT activity.
    Small M; Lasser-Weiss M; Daniel V
    J Immunol; 1979 Jul; 123(1):259-62. PubMed ID: 312875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
    Chou T; Bertera S; Chang AE; Shu S
    J Immunol; 1988 Sep; 141(5):1775-81. PubMed ID: 3261761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated lymphoid cells: analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration.
    Schick B; Berke B
    Transplant Proc; 1977 Mar; 9(1):1157-60. PubMed ID: 867485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    Blazar BA; Miller FR; Heppner GH
    J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the immature cells involved in T cell-mediated enhancement of syngeneic tumor growth.
    Small M
    J Immunol; 1977 May; 118(5):1517-23. PubMed ID: 300747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY; Chou T; Sakai K
    J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.